logo
ProjectArchived

Pharmacogenomics Knowledge Base (R24)

Sector: Government • Location: United States of America

Source: Grants.gov

This funding opportunity announcement (FOA) offers support for a high impact pharmacogenomics knowledge base as a research resource available to the entire scientific community. There is an existing Pharmacogenomics Knowledge Base, PharmGKB, and it is the intention of NIGMS to continue one knowledge base. This is an open competition and any qualified applicants are invited to respond. Advance c

Status
Closed
Sector
Government, Rail, Education
Location
United States of America
Updated
22 Jul 2026
Source
Grants.gov

ConstructChat

Ask ConstructChat about Pharmacogenomics Knowledge Base (R24)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “Pharmacogenomics Knowledge Base (R24)” is an infrastructure initiative in the Government sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Participants

Sponsoring Agency

Status

Original status

archived

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

This funding opportunity announcement (FOA) offers support for a high impact pharmacogenomics knowledge base as a research resource available to the entire scientific community. There is an existing Pharmacogenomics Knowledge Base, PharmGKB, and it is the intention of NIGMS to continue one knowledge base. This is an open competition and any qualified applicants are invited to respond. Advance consultation with staff to ensure that a proposed resource fits well with this opportunity is highly encouraged.

Budget

Location

Country

United States of America (USA)

Source

Source reliability

High

Source

Grants.gov

URL

More Details

Record type

Project

Sector

Government, Rail, Education

Article published date

2023-06-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project